Integra LifeSciences IART Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's accounts receivable?
- Integra LifeSciences (IART) reported accounts receivable of $264.41M in Q1 2026.
- How has Integra LifeSciences's accounts receivable changed year-over-year?
- Integra LifeSciences's accounts receivable increased by 4.7% year-over-year, from $252.45M to $264.41M.
- What is the long-term trend for Integra LifeSciences's accounts receivable?
- Over 5 years (2020 to 2025), Integra LifeSciences's accounts receivable has grown at a 4.3% compound annual growth rate (CAGR), from $225.53M to $278.85M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.